Understanding cooperativity in human P450 mediated drug-drug interactions

被引:20
|
作者
Sligar, Stephen G.
Denisov, Ilia G.
机构
[1] Univ Illinois, Dept Biochem, Coll Med, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Chem, Coll Med, Urbana, IL 61801 USA
[3] Univ Illinois, Ctr Biophys & Comp Biol, Urbana, IL 61801 USA
关键词
cytochrome P450; CYP3A4; homotropic cooperativity; heterotropic cooperativity; dose-response function;
D O I
10.1080/03602530701498521
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multiple drugs can interact, often leading to adverse side effects. One well documented site for these interactions includes the group of cytochrome P450 monoxygenases. Several human hepatic systems are known to bind more than a single substrate molecule which can give rise to the terms "homotropic and heterotopic cooperativity" to define the resultant thermodynamic and kinetic properties observed in drug metabolism in vestigations. We provide a means for understanding and quantitating these drug-drug interactions by documenting the functional properties of the various states of the enzyme and show that, even in the absence of true binding cooperativity, significant non-Michaelis metabolic profiles are possible.
引用
收藏
页码:567 / 579
页数:13
相关论文
共 50 条
  • [1] Inactivation of Human Cytochrome P450 Enzymes and Drug-Drug Interactions
    Obach, R. Scott
    Fahmi, Odette A.
    Walsky, Robert L.
    ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 473 - 495
  • [2] Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions
    Tang, W
    Stearns, RA
    CURRENT DRUG METABOLISM, 2001, 2 (02) : 185 - 198
  • [3] In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms
    Dmitriev, Alexander V.
    Rudik, Anastassia V.
    Karasev, Dmitry A.
    Pogodin, Pavel V.
    Lagunin, Alexey A.
    Filimonov, Dmitry A.
    Poroikov, Vladimir V.
    PHARMACEUTICS, 2021, 13 (04)
  • [4] Quantitative prediction of intravenous drug-drug interactions mediated by cytochrome P450 perpetrators
    Tuloup, V.
    Tod, M.
    Bourguignon, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 25 - 25
  • [5] Drug-drug interactions and the cytochrome P450 system: An update
    Shannon, M
    PEDIATRIC EMERGENCY CARE, 1997, 13 (05) : 350 - 353
  • [6] Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer
    Denisov, Ilia G.
    Grinkova, Yelena V.
    Baylon, Javier L.
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2015, 54 (13) : 2227 - 2239
  • [7] The impact of cytochrome P450 allosterism on pharmacokinetics and drug-drug interactions
    Shou, MG
    DRUG DISCOVERY TODAY, 2004, 9 (15) : 636 - 637
  • [8] Structural promiscuity of human cytochromes P450: Understanding drug-drug interactions and metabolism via in silico fragment mapping
    Ngan, Chi Ho
    Napoleon, Raeanne L.
    Kozakov, Dima
    Vajda, Sandor
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [9] In Vitro Techniques to Study Drug-Drug Interactions of Drug Metabolism: Cytochrome P450
    Houston, J. Brian
    Galetin, Aleksandra
    ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 169 - 215
  • [10] Molecular mechanisms of cytochrome P450 induction: Potential for drug-drug interactions
    Jana, Snehasis
    Paliwal, Jyoti
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2007, 8 (06) : 619 - 628